September/October 2024

Featured Article

Perspectives

Who Uses Pathways Around Care Management?

10/01/2024

This pilot study provides a brief literature review on users, uses, and a recent electronic survey to determine how users use clinical pathways along with their feedback around their value.

This pilot study provides a...

10/01/2024

Journal of Clinical Pathways

Column

Editor's Page

Solutions for a Broken Health Care System

10/02/2024

Winston Wong , PharmD;

Editor-in-Chief Winston Wong, PharmD, provides insights on this issue’s content, including critical issues in the health care system, emphasizing the need for innovative solutions to improve accessibility, affordability, and quality of care.

Editor-in-Chief Winston Wong,...

10/02/2024

Journal of Clinical Pathways

COA Viewpoint

A Long Time Coming: Is Pharmacy Benefit Manager Reform Finally Here?

10/01/2024

Nicolas Ferreyros ;

This column discusses the growing movement for pharmacy benefit manager (PBM) reform and the latest developments from the US Congress to protect patients from PBM abuses.

This column discusses the...

10/01/2024

Journal of Clinical Pathways

Transformative Employer Trends

Key Strategic Coverage Decision Trends for 2025

10/01/2024

F. Randy Vogenberg , PhD, FASHP;

This column highlights key 2024 trends that have influenced employer benefit decision-making in the US that will continue through 2025 and beyond.

This column highlights key 2024...

10/01/2024

Journal of Clinical Pathways

MAI Mindset

Common Strategies for Cancer Drug Management

10/01/2024

Lee Blansett , MBA;

This entry of our MAI Mindset column discusses formularies and order sets, two internal structures and processes that guide oncology treatment selection.

This entry of our MAI Mindset...

10/01/2024

Journal of Clinical Pathways

Feature

Perspectives

Facing Cancer as a Chronic Disease: Shared Decision-Making at Critical Points in a Long Illness Journey

10/01/2024

Christine M. Wilson , MS;

Gwen Darien ;

Kathleen D. Gallagher , MPH;

Alan J. Balch , PhD, MSc;

In this third installment of a three-part series on decision support tools and shared decision-making, Christine Wilson, MA, MS, and colleagues describe how patients within three diverse communities who are living with cancer understand and...

In this third installment of a...

10/01/2024

Journal of Clinical Pathways

Current Issue

October 2024

Volume 10

Issue 5

Current Issue

Issue Archive

Special Reports

Sponsored

JCP Special Report

The Value of Tissue-Based Genomic Profiling in Oncology

09/17/2024

Innovations in precision oncology have helped healthcare providers to create more personalized treatment plans and improve patient outcomes. View this special report to learn more.

Innovations in precision...

09/17/2024

Journal of Clinical Pathways

Sponsored

Special Report

Shedding Light on Non-Small Cell Lung Cancer & Its Impact on Patients

04/03/2023

This supplement aims to raise awareness about non-small cell lung cancer (NSCLC) and its impact on patients by providing comprehensive information to help improve early detection and appropriate care.

This supplement aims to raise...

04/03/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Brukinsa® (Zanubrutinib) for Chronic Lymphocytic Leukemia

03/31/2023

In this product monograph, read an interview with Jeff P. Sharman, MD, as he discusses important BRUKINSA® trial data including efficacy, safety, dosing, administration, and other relevant data. These key findings supported the Food and Drug...

In this product monograph, read...

03/31/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Tumor Lysis Syndrome: Early Diagnosis and Management

01/04/2023

This review summarizes the diagnosis, pathophysiology, and evidence-based guidelines for the prevention and management of tumor lysis syndrome, a common, acute, life-threatening disease primarily in patients with hematologic cancers and solid...

This review summarizes the...

01/04/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

A Tumor Lysis Syndrome Risk Assessment and Its Impact on Patients

08/09/2022

In an interview with Journal of Clinical Pathways, Nicholas Short, MD, shares objectives on the design and benefits of MD Anderson’s Tumor Lysis Syndrome clinical assessment for patient risk and impact on patient care.

In an interview with Journal of...

08/09/2022

Journal of Clinical Pathways

Updated NCCN Guidelines on B-Cell Lymphomas

Sponsored

JCP Special Report

Overview of the Updated NCCN Guidelines on B-Cell Lymphomas

06/15/2022

Robert Fee ;

Updated multiple times in 2022, the National Comprehensive Cancer Network (NCCN) Guidelines for B-Cell Lymphomas provide recommendations for the prevention, diagnosis, and management of malignancies.

Updated multiple times in 2022,...

06/15/2022

Journal of Clinical Pathways

Sponsored

Special Report

Expanded Indication for Zanubrutinib: Marginal Zone Lymphoma and Waldenström’s Macroglobulinemia

06/10/2022

In an interview with Journal of Clinical Pathways, Mitul Gandhi, MD, reviews the clinical impact and treatment approaches and challenges for patients with marginal zone lymphoma and Waldenström’s macroglobulinemia.

In an interview with Journal of...

06/10/2022

Journal of Clinical Pathways

JCP Special Report

Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group

05/20/2022

Robin T. Zon , MD, FACP, FASCO;

Gordon Kuntz ;

Winston Wong , PharmD;

The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...

The Journal of Clinical Pathways...

05/20/2022

Journal of Clinical Pathways

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

Sponsored

Special Report

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

12/15/2021

Deborah Abrams Kaplan ;

NCCN released updates to its practice guidelines on treating triple-negative breast cancer, featuring updates on sacituzumab govitecan recommendations and more.

NCCN released updates to its...

12/15/2021

Journal of Clinical Pathways

Sponsored

Special Report

Navigating the Patient Journey for Unresectable Stage III Non-Small Cell Lung Cancer

09/16/2021

.ryan-test { display: none; } .body-content h3 { font-size: 18px; line-height: 18px; color: #000000; font-weight: 600px; } .related-content { display: none; } .body-content div > div:nth-of-type(3) .paragraph > h3 >...

.ryan-test { display:...

09/16/2021

Journal of Clinical Pathways

Journal of Clinical Pathways Newsletter

Editorial Correspondence

September/October 2024

Featured Article

Column

Feature

Current Issue

Special Reports

Subscribe

October 2024 Volume 10 Issue 5

Specialties

Events

Year Round Education

HMP Global Products